Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.12890/2020_001938 http://scihub22266oqcxt.onion/10.12890/2020_001938 33194871!7655002!33194871     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Eur+J+Case+Rep+Intern+Med 2020 ; 7 (11): 001938 Nephropedia Template TP {{tp|p=33194871|t=2020. Late Worsening of COVID-19 Pneumonia: Successful Treatment with Ruxolitinib and Steroid |pdf=|usr=}}{{33194871}} gab.com Text Late Worsening of COVID-19 Pneumonia: Successful Treatment with Ruxolitinib and Steroid JO: Eur J Case Rep Intern Med http://www.kidney.de/pget.php?&tw=1&pmid=33194871 #FOAvip We describe the case of a patient hospitalized for the second time in a month due to delayed worsening of lung lesions in COVID-19 infection without bacterial superinfection. He was treated with hydroxychloroquine, IV dexamethasone and ruxolitinib with rapid improvement of respiratory failure; 1 month after the second discharge, maintaining low-dose oral prednisone, lung consolidations were significantly reduced on control CT. LEARNING POINTS: Modulation of immune over-response in late phases of COVID-19 can influence global outcome.Ruxolitinib and IV steroids can reverse the inflammatory process and lung lesions. Twit Text FOAVip Late Worsening of COVID-19 Pneumonia: Successful Treatment with Ruxolitinib and Steroid ????Eur J Case Rep Intern Med http://www.kidney.de/pget.php?&tw=1&pmid=33194871 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33194871 #FOAvip English Wikipedia <ref>{{Cite pmid|33194871}}</ref> Late Worsening of COVID-19 Pneumonia: Successful Treatment with Ruxolitinib and Steroid #MMPMID33194871 Betelli M; De Stefano F; Tedeschi A Eur J Case Rep Intern Med 2020[]; 7 (11): 001938 PMID33194871show ga We describe the case of a patient hospitalized for the second time in a month due to delayed worsening of lung lesions in COVID-19 infection without bacterial superinfection. He was treated with hydroxychloroquine, IV dexamethasone and ruxolitinib with rapid improvement of respiratory failure; 1 month after the second discharge, maintaining low-dose oral prednisone, lung consolidations were significantly reduced on control CT. LEARNING POINTS: Modulation of immune over-response in late phases of COVID-19 can influence global outcome.Ruxolitinib and IV steroids can reverse the inflammatory process and lung lesions. äLate Worsening of COVID-19 Pneumonia: Successful Treatment with Ruxoli(epmc).pdf DeepDyve Pubget Overpricing